CNTFRα Activators
The chemical class of CNTFRα activators encompasses a range of compounds that indirectly influence the activity of CNTFRα through modulation of various signaling pathways and cellular processes. These activators do not directly interact with CNTFRα; rather, they affect pathways or mechanisms that are interconnected with the function of CNTFRα, leading to its activation.
Compounds such as cAMP, Forskolin, and Rolipram demonstrate the role of cAMP-dependent pathways in modulating cellular signaling. These compounds, by elevating intracellular cAMP levels or mimicking its action, activate protein kinases like PKA, which in turn can influence signaling pathways that intersect with those regulating CNTFRα. The involvement of calcium signaling is highlighted by compounds like A23187 and Thapsigargin, which alter intracellular calcium levels and thereby affect calcium-dependent pathways linked to CNTFRα activity.
Additionally, the use of Lithium Chloride and its effect on the Wnt signaling pathway exemplifies how inhibition of certain enzymes can lead to downstream changes in signaling pathways, indirectly influencing CNTFRα activity. The inclusion of BDNF mimetic compounds reflects an understanding of the interplay between neurotrophic factors and receptor signaling in the nervous system, further emphasizing the complexity of targeting specific receptors like CNTFRα
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP can activate PKA, which may modulate signaling pathways intersecting with those of CNTFRα, leading to its indirect activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, thereby activating PKA and influencing pathways that could indirectly activate CNTFRα. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate signaling pathways intersecting with CNTFRα, potentially influencing its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, a part of the Wnt signaling pathway. This inhibition can lead to downstream effects that might indirectly activate CNTFRα. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a PDE4 inhibitor, Rolipram raises cAMP levels, potentially influencing signaling pathways that intersect with CNTFRα. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, a non-selective phosphodiesterase inhibitor, increases cAMP and cGMP levels, potentially modulating pathways influencing CNTFRα. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog can activate cAMP-dependent pathways, potentially leading to the indirect activation of CNTFRα. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium, activating calmodulin-dependent pathways that could intersect with CNTFRα, influencing its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels by inhibiting ER calcium ATPase, potentially affecting pathways that intersect with CNTFRα. | ||||||